Doug BA - Dyadic International Executive Development
| DYAI Stock | USD 1.49 0.01 0.67% |
Executive
Doug BA is Executive Development of Dyadic International
| Address | 1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094 |
| Phone | 561 743 8333 |
| Web | https://www.dyadic.com |
Dyadic International Management Efficiency
The company has return on total asset (ROA) of (0.4669) % which means that it has lost $0.4669 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8011) %, meaning that it created substantial loss on money invested by shareholders. Dyadic International's management efficiency ratios could be used to measure how well Dyadic International manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.87. The Dyadic International's current Return On Capital Employed is estimated to increase to -1.3. The current Total Assets is estimated to decrease to about 7.8 M. The current Other Assets is estimated to decrease to 6,604Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MBA III | Celcuity LLC | 63 | |
| Daniel George | Anebulo Pharmaceuticals | 54 | |
| Marc MD | Pmv PharmaceuticalsInc | N/A | |
| Nicole Esq | HCW Biologics | N/A | |
| Binh Vu | Pmv PharmaceuticalsInc | N/A | |
| Jolie JD | C4 TherapeuticsInc | 47 | |
| Anne DVM | Molecular Partners AG | N/A | |
| Marianna Zipeto | Champions Oncology | N/A | |
| Karin Heidemann | Champions Oncology | N/A | |
| Keith Baker | Kineta Inc | 57 | |
| Marc MD | Edgewise Therapeutics | 67 | |
| Julie CCRP | DiaMedica Therapeutics | 50 | |
| John Moore | Edgewise Therapeutics | 60 | |
| Joshua JD | AN2 Therapeutics | 46 | |
| Mark Weinstein | Champions Oncology | N/A | |
| Arthur Hanson | Champions Oncology | N/A | |
| MD MBA | Molecular Partners AG | N/A | |
| Robert Hendriks | Molecular Partners AG | N/A | |
| Susan Foreman | Champions Oncology | N/A | |
| Michael Carulli | Pmv PharmaceuticalsInc | N/A | |
| Renate Gloggner | Molecular Partners AG | 54 | |
Management Performance
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.47 |
Dyadic International Leadership Team
Elected by the shareholders, the Dyadic International's board of directors comprises two types of representatives: Dyadic International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dyadic. The board's role is to monitor Dyadic International's management team and ensure that shareholders' interests are well served. Dyadic International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dyadic International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Emalfarb, Founder, CEO and President Director and Chairman of Nominating Committee | ||
| Robert Burke, Director | ||
| Joseph Hazelton, Chief Officer | ||
| Stephen Warner, Director | ||
| Jack Kaye, Director | ||
| Ping Rawson, Principal Financial Officer, Chief Accounting Officer | ||
| Ronen Tchelet, VP of Bus. Devel. for Europe | ||
| Thomas Dubinski, CFO, VP and Corporate Secretary | ||
| Arindam Bose, Director | ||
| Andre Klaassen, Director of Marketing and Sales - EMEA | ||
| Seth Herbst, Director | ||
| Frank Gerardi, Director | ||
| Michael Tarnok, Director | ||
| Doug BA, Executive Development | ||
| Thomas OShaughnessy, VP of Sales and Marketing | ||
| Richard Jundzil, VP of Operations | ||
| Ana Rodriguez, Secretary Board | ||
| Barry Buckland, Director |
Dyadic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dyadic International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.47 | ||||
| Profit Margin | (2.34) % | ||||
| Operating Margin | (3.16) % | ||||
| Current Valuation | 36.33 M | ||||
| Shares Outstanding | 28.97 M | ||||
| Shares Owned By Insiders | 30.87 % | ||||
| Shares Owned By Institutions | 15.57 % | ||||
| Number Of Shares Shorted | 184.34 K | ||||
| Price To Earning | (18.70) X |
Pair Trading with Dyadic International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyadic International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyadic Stock
| 0.63 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
Moving against Dyadic Stock
| 0.64 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.44 | IPSC | Century Therapeutics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Dyadic International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyadic International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyadic International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyadic International to buy it.
The correlation of Dyadic International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyadic International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyadic International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyadic International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyadic International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Dyadic Stock please use our How to Invest in Dyadic International guide.Note that the Dyadic International information on this page should be used as a complementary analysis to other Dyadic International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Dyadic Stock analysis
When running Dyadic International's price analysis, check to measure Dyadic International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyadic International is operating at the current time. Most of Dyadic International's value examination focuses on studying past and present price action to predict the probability of Dyadic International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyadic International's price. Additionally, you may evaluate how the addition of Dyadic International to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Dyadic International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyadic International. If investors know Dyadic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyadic International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Revenue Per Share 0.101 | Quarterly Revenue Growth (0.08) | Return On Assets (0.47) | Return On Equity (0.80) |
The market value of Dyadic International is measured differently than its book value, which is the value of Dyadic that is recorded on the company's balance sheet. Investors also form their own opinion of Dyadic International's value that differs from its market value or its book value, called intrinsic value, which is Dyadic International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyadic International's market value can be influenced by many factors that don't directly affect Dyadic International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyadic International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyadic International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyadic International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.